The Global. Sandoz plans to launch five biosimilars of the leading biologic medicines in oncology and immunology in key geographic areas by 2020, with the goal of expanding access to these treatments to a greater number of patients.
recently published
Horizon scanning
Jan 31 2024
Early Treatment: the role of biosimilars
18 2023 December
